News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News Short-term Changes in Exercise Habits Can Alter Long-term Prognosis of Stable CAD Patients Caitlin E. Cox October 26, 2017
News Daily News Statins and Diabetes: Causal Link Reinforced in New Analysis Michael O'Riordan October 25, 2017
News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Daily News CTA Reduces MI Compared With Functional Stress Testing, but at a Cost Michael O'Riordan October 05, 2017
News Daily News Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death Caitlin E. Cox October 04, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Conference News ESC 2017 Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1 Michael O'Riordan September 05, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017
News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
News Conference News ESC 2017 Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed Michael O'Riordan August 29, 2017
News Conference News ESC 2017 PURE Investigators: Rethink Diet Guidance to Plug More Fats, Fewer Carbs Shelley Wood August 29, 2017
News Conference News ESC 2017 Less Is More? Health Benefits of Fruits, Vegetables, and Legumes Seen at Lower Intake Levels Michael O'Riordan August 29, 2017
News Conference News ESC 2017 Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab Michael O'Riordan August 28, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017